Uniting Hearts and Pooling Strength to Achieve New Glory—The YUANZHI Yunnan Listing Third Anniversary Gratitude Gala Was Held Successfully

Release Date:

2021-12-17

author：

On December 2, the “Three-Year Anniversary Gratitude and Appreciation Event for Yuanzhi’s Listing in Yunnan,” hosted by Luoyang Huizhong Biotechnology Co., Ltd., was successfully held in Kunming, Yunnan. At 9:00 a.m., Mr. Yao Hengliang, Marketing Director of Huizhong Biotechnology’s Southwest Region, delivered a welcome address, extending his sincerest gratitude to all leaders, experts, and distinguished guests in attendance. More than 170 outstanding partners from Yunnan, Guizhou, and Chongqing gathered to witness this grand occasion. At the start of the conference, Mr. Wang Bingfei, Deputy General Manager of Huizhong Biotechnology, presented a special report titled “Overview and Development Plan of Huizhong Biotechnology.” He stated, “In 2018, Huizhong Biotechnology successfully launched China’s first bivalent inactivated vaccine against Mycoplasma hyopneumoniae and swine circovirus, quickly earning market recognition and acclaim. Subsequently, the company introduced an upgraded version of its bivalent vaccine—‘Yuanzhi 3.0’—featuring a completely new manufacturing process that further enhances protection against both pathogens.” Mr. Wang emphasized, “Combined vaccines will become the future trend in swine vaccination. Upholding our philosophy of ‘integrity and prudent management, innovation for the future,’ we remain committed to providing high‑tech, high‑standard, highly efficient, and cost‑effective ‘4G’ products, setting benchmarks, leading the industry, continuously innovating, and introducing new solutions to safeguard the healthy development of the livestock sector.” ▲ Mr. Wang Bingfei, Deputy General Manager of Huizhong Biotechnology, delivers a speech. Next, Mr. Gu Shuai, Technical Director of Huizhong Biotechnology’s Swine Vaccine Division, shared insights on the application of the “Yuanzhi 3.0” solution and strategies for preventing and controlling diarrhea in pig farms. Starting from the current state of the swine industry, he conducted a thorough analysis of how farms can scientifically reduce disease burdens, appropriately implement combined immunization protocols, and identify factors influencing such combined approaches. Regarding diarrhea prevention, he explained, “Drawing on practical production experience and disease‑control needs, Huizhong Biotechnology has developed a ‘live + inactivated’ immunization strategy—combining the live vaccine Huibuning with the inactivated vaccine Huibian’an—which offers enhanced protection, particularly for newborn piglets. Diarrhea is a multifactorial condition requiring comprehensive preventive measures. To address this, we have formed strong partnerships with the National Veterinary Drug Engineering Technology Research Center, Zhongke Gene, and Putai Biotechnology, establishing five key prevention systems: early epidemiological surveys for diarrheal diseases, risk assessments and early warnings, pathogen isolation, identification, and research, post‑disease treatment and improved management guidance, and evaluations of immune response effectiveness—truly helping farmers solve real‑world challenges.” ▲ Mr. Gu Shuai, Technical Director of Huizhong Biotechnology’s Swine Vaccine Division, shares technical expertise. The conference also featured a lively gratitude promotion event, with enthusiastic participation from partners. As exciting prizes were awarded one after another, the atmosphere grew increasingly jubilant. Following this, partners shared their experiences and impressions after using Huizhong Biotechnology’s products, expressing confidence in and hopes for continued collaboration. The event concluded successfully in a cheerful and spirited atmosphere.

On December 2, the “Three-Year Anniversary Gratitude and Appreciation Event for Huizhong Biotechnology Co., Ltd.’s Listing in Yunnan” was successfully held in Kunming, Yunnan. At 9:00 a.m., Mr. Yao Hengliang, Marketing Director of Huizhong Biotechnology’s Southwest Region, delivered a welcoming address, extending his sincerest gratitude to all leaders, experts, and distinguished guests in attendance. More than 170 outstanding partners from Yunnan, Guizhou, and Chongqing gathered to witness this momentous occasion.

At the outset of the meeting, Mr. Wang Bingfei, Deputy General Manager of Huizhong Bio, presented a special report titled “Overview and Development Plan of Huizhong Bio.” He stated: “In 2018, Huizhong Bio successfully launched the nation’s first bivalent inactivated vaccine against Mycoplasma hyopneumoniae and porcine circovirus, which quickly earned widespread market recognition and acclaim. Subsequently, the company introduced an upgraded bivalent vaccine—‘Yuanzhi 3.0’—featuring a completely new manufacturing process and incorporating attenuated classical swine fever virus.” Mr. Wang emphasized: “Combination vaccines will be the future trend in swine vaccination. Upholding our guiding principle of ‘upright and prudent management, innovation for the future,’ we will continue to position ourselves with a ‘4G’ product strategy—high technology, high standards, high efficiency, and high cost-effectiveness—to deliver premium products and services to farmers, set industry benchmarks, lead the sector, and relentlessly innovate and introduce new solutions, thereby safeguarding the healthy development of the livestock industry.”

▲ Wang Bingfei, Deputy General Manager of Huizhong Bio, delivered a speech.

Next, Gu Shuai, Technical Director of the Pig‑Vaccine Division at Huizhong Bio, presented an in-depth discussion on the application of the “Yuanzhi 3.0 Protocol” and strategies for preventing and controlling diarrhea in pig farms. Starting from the current landscape of the swine industry, he thoroughly examined how farms can scientifically reduce disease burdens, how to appropriately implement combined immunization regimens, and the factors influencing such approaches. Regarding diarrhea prevention, he explained: “Drawing on practical production needs and disease‑control requirements, Huizhong Bio has developed a ‘live‑plus‑inactivated’ immunization strategy—combining the live bivalent vaccine Huibuning with the inactivated vaccine Huibian’an—which provides robust protection, particularly for neonatal piglets. Diarrhea is a multifactorial syndrome, necessitating comprehensive preventive measures. To address this, the company has formed strong partnerships with the National Veterinary Drug Engineering Technology Research Center, Zhongke Gene, and Putai Bio, offering farmers five key preventive systems: early epidemiological surveys for diarrhea‑related diseases, risk assessment and early warning, pathogen isolation, identification, and research, post‑disease treatment and guidance on improving management practices, and evaluation of vaccination efficacy—truly delivering solutions that meet real‑world challenges.”

▲ Gu Shuai, Technical Director of the Pig Breeding Division at Huizhong Bio, delivered a technical presentation.

At the meeting, a lively gratitude‑based promotional event was held, with partners enthusiastically participating and the atmosphere steadily building as exciting prizes were awarded one after another. Following this, partners shared their experiences and impressions of the products, expressing both their approval and satisfaction while also voicing confidence in and high hopes for their collaboration with Huizhong Bio. The event concluded successfully in a cheerful and spirited atmosphere.

Standing Together Through Storms, Forging Ahead with Determination | Huizhong Bio’s Year-End Appreciation Event (Shandong Station) Concludes Successfully

Staying True to Our Original Aspiration and Forging Ahead | Huizhong Bio Hosts Its 2020 Autumn Running Event